Physician
Hematology
Dr. Suparna B. Wedam, MD
|
|
Give Review
Suparna Wedam practices Hematology. He researched medicine at Georgetown University School of Medicine. Georgetown University School of Medicine has a rank of 49 in research and a 84 in primary care Suparna Wedam is a published MD as well. He has 7 publications published. The latest was: First FDA Approval of Neoadjuvant Therapy for Breast Cancer: Pertuzumab for the Treatment of Patients with HER2-Positive Breast Cancer.
Publications
- First FDA Approval of Neoadjuvant Therapy for Breast Cancer: Pertuzumab for the Treatment of Patients with HER2-Positive Breast Cancer.
- Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experience.
- Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer.
- Contralateral breast cancer: where does it all begin?
- Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer.
- Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancer.
Schools
Georgetown University
National Canc Institute
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
- Medicare MCR
- Tricare
Education
-
Georgetown University Hospital -
Georgetown University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Joseph A. Frank, MD |
|
|
Dr. Sanjeeve Balasubramaniam, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret E. Rick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Irina G. Veytsman, MD
This Doctor is OpenDoctor Recommended.
|